Imprimis NJOF, LLC recalls Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 Wes
Recalled July 30, 2025 · FDA recall D-0535-2025 · Imprimis NJOF
Hazard
Sub-Potent Drug: Subpotent assay results during stability testing. · FDA Class II
Units
6,880 vials
Sold at
Nationwide in the USA
Description
Sub-Potent Drug: Subpotent assay results during stability testing.
Product
Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01
Manufacturer(s)
Imprimis NJOF, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →